Description

Stanotrex 10 mg by Novotex Pharma contains Stanozolol, an oral anabolic-androgenic steroid (AAS) historically developed for the medical treatment of conditions such as hereditary angioedema, osteoporosis, and muscle-wasting disorders. Stanozolol is noted for its mild androgenic profile and strong anabolic effects, with unique properties that have been studied for reducing edema, improving lean tissue retention, and promoting recovery.

Stanotrex 10 mg is manufactured to pharmaceutical standards, ensuring precise dosing in each tablet. Packaged in bottles of 100 tablets, it is suitable for use in analytical and laboratory settings that require controlled compound study environments.

Product Details

• Active Ingredient: Stanozolol

• Concentration per Tablet: 10 mg

• Form: Oral tablets

• Package Size: 100 tablets per bottle

Pharmacokinetics

Stanozolol has a half-life of approximately 8–9 hours, with a distinct anabolic-to-androgenic ratio and no conversion to estrogen. It is known for its ability to increase nitrogen retention and protein synthesis, making it a useful compound in studies focused on tissue recovery and catabolic conditions.

Usage Recommendations

• Typical Medical Dosage (historic use): 2–6 mg per day for conditions like angioedema, under physician supervision.

• Current Use: For laboratory and analytical purposes.

• Administration: Oral

Disclaimer

This product is intended strictly for laboratory and analytical applications. It is not approved for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical conditions. Always adhere to local regulations and professional research standards.